442-E A novel targeted, type I interferon producing, innate lymphocyte therapy with potent anti-tumor activity
Anders Laustsen(Aarhus University), Martin R. Jakobsen(Aarhus University), Nicolai O. Haahr, Rasmus O. Bak(Aarhus University), Trine I. Jensen(Aarhus University), Jonas Bruun Vejlebo, Ditte Elisabeth Jæhger, Iulia Diaconu, Kasper M Jensen, Tobias Wang Bjerg(Aarhus University), Aida S. Hansen(Aarhus University)
Cited by 0
Related Papers
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
|Molecular Cell|2018|663
Attenuation of c <scp>GAS</scp> ‐ <scp>STING</scp> signaling is mediated by a p62/ <scp>SQSTM</scp> 1‐dependent autophagy pathway activated by TBK1
|The EMBO Journal|2018|480
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
|Nature Communications|2020|464
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
|Proceedings of the National Academy of Sciences|2013|342
cGAS is activated by DNA in a length‐dependent manner
|EMBO Reports|2017|304